ACUT
Accustem Sciences Inc.
Key Financials
Net Income
$-1756096
↓ 16.7%
EPS (Diluted)
$-0.12
↑ 7.7%
Total Assets
$1.5M
↑ 2947.0%
Total Liabilities
$5.0M
↑ 47.2%
Shareholders' Equity
$-3401625.00
↓ 2.7%
Operating Cash Flow
$-850389.00
↓ 28.1%
Operating Income
$-1756096
↓ 16.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 4/14/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 8-K | 11/26/2025 | View on SEC |
| 10-Q | 11/12/2025 | View on SEC |
| 10-Q | 8/14/2025 | View on SEC |
| 4 | 6/16/2025 | View on SEC |
| 4 | 6/13/2025 | View on SEC |
| 10-Q | 5/20/2025 | View on SEC |
| NT 10-Q | 5/15/2025 | View on SEC |
| 4 | 4/10/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACUT |
| Company Name | Accustem Sciences Inc. |
| CIK | 1850767 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 442070661000 |